Hepatoprotective Effect of Cassia Fistula Linn. by Wasu, S. J. & Muley, B. P.
Ethnobotanical Leaflets 13: 910-16. 2009.
 
Hepatoprotective Effect of Cassia Fistula Linn.
*S.J. Wasu and B.P. Muley
Siddhivinayak College of Pharmacy, Warora, Chandrapur- 442 907, India
*For Correspondence: swasu087@gmail.com
 
ABSTRACT
A number of herbal preparations are used throughout the world for the management of the hepatic disorders. However, 
many of them have not been investigated for their described effects. Cassia fistula Linn. is one such drug used in the 
treatment of hepatitis in folk medicine. Therefore, an attempt was made to investigate the hepatoprotective effect of 
leaves and bark of Cassia fistula against carbon tetrachloride (CCl4) induced hepatotoxicity in rats. Sixty albino 
Wistar rats were divided into six equal groups of 10. Four groups received extracts leaves/bark of Cassia fistula and 
intraperitoneal (i.p.) CCl4 (0.2 ml/100 g) either before or after administration of extracts. Two groups were controls, 
one treated with CCl4 and one with normal saline. Liver damage was assessed by plasma concentration of bilirubin 
and enzyme activities of aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase. Treatment 
with aqueous extract of leaves and bark significantly reduced CCl4 -induced elevation in plasma enzyme and bilirubin 
concentration in rats. This study demonstrated that CCl4 -induced liver damage in rats can be ameliorated by treatment 
of extracts from leaves and bark.
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INTRODUCTION
Liver is the key organ for detoxification and disposition of endogenous substances. It is continuously and widely 
exposed to xenobiotics, hepatotoxins, and chemotherapeutic agents that lead to impairment of its functions1. Cassia 
fistula (Leguminoceae) is known as amaltas (Hindi), bahava (Marathi). It is a deciduous, medium sized tree upto 24 m 
in height with straight bole upto 15 m, found both wild and cultivated almost throughout India. The leaves reported to 
contain flavonoids like quercetin, kaempferol along with anthraquinone glycosides while bark is rich in flavonoids 
like lupeol, epicatechin and tannins2. Literature survey revealed that no scientific study is reported regarding its 
hepatoprotective activity of Cassia fistula. Therefore, the present study was conducted to investigate its 
hepatoprotective activity.
 
MATERIAL & METHODS
Plant Material
Leaves and bark of Cassia fistula were obtained from Amaravati District, Maharashtra. The plant samples were 
identified and authenticated in the Herbarium by botanist Dr. Prabha Y. Bhogaonkar, VMV, Botany Department, 
Amaravati, Maharashtra, India. The leaves and bark were macerated by using water as a menstrum. The obtained 
extract was dried and concentrated under freezed drier and kept tied closed into container.  
 
Animals 
The Institutional Animal Ethics Committee approved the animal studies. It includes Albino Wistar rats of either sex, 
weighing 180-200 g. All animals were given standard diet and water ad libitum. They were maintained at a relative 
humidity of 65 to 86%, a temperature of 23 to 25°C, and in a schedule of 12 h of light and 12 h of dark. Rats were 
weighed at the beginning and end of the study.
Chemicals 
CCl4 was obtained from Sigma-Aldrich. All other chemicals used were of analytical grade.  
Assessment of Hepatoprotective Activity
Sixty animals were randomly divided equally into six groups of 10 each. 
Group 1 (controls): received normal saline orally (0.2 ml/100 g) for 16 consecutive days.
 
Group 2 (pretreatment experiment-leaves extract): allowed free access to aqueous extract of leaves ad libitum for 28 
consecutive days and treated with i.p. CCl4 on Days 14, 15, and 16 of the treatment period.
 
Group 3 (post-treatment experiment-leaves extract): given aqueous extract of leaves  ad libitum for 14 consecutive 
days and treated with i.p. CCl4 on Days 1, 2, and 3 of the treatment period.
 
Group 4 (pretreatment experiment-bark extract): allowed aqueous extract of bark ad libitum for 28 consecutive days 
and treated with i.p. CCl4 on Days 14, 15, and 16 of the treatment period.
 
Group 5 (post-treatment experiment-bark extract): given aqueous extract of bark ad libitum for 14 consecutive days 
and treated with i.p. CCl4 on Days 1, 2, and 3 of the treatment period.
 
Group 6 (CCl4 -treated control): injected i.p. with a fresh mixture of equal volumes of CCl4 and olive oil for three 
consecutive days at the dose of 0.2 ml/100 g of body weight/day.  
 
Twenty-four hours after the last treatment, the rats were euthanized by injecting i.p. sodium pentobarbitone (100 g/
kg). Hepatoprotective activity was calculated3.
  
Hepatoprotective activity (%) = 1 - (PC - S)/(C - S) x 100 where PC, C, and S are the measurable variables in rats 
treated with Cassia fistula leaves/bark extract with CCl4, CCl4, and saline-treated animals, respectively.
 
Blood Sampling
Blood was collected in heparinized tubes from the inner canthus on the 29th day or the 16th day in the pre or post-
treated groups, respectively. Plasma was separated by centrifugation at 900 rpm for 10 min at 4°C and used for 
determining the activities of aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase 
(ALP), and bilirubin concentration using the Hitachi autoanalyzer-902.  
 
Statistical Analysis
Values reported are means ± SE (n = 10). Experimental results were statistically analyzed using the Student's t -test 
followed by ANOVA. P value less than 0.01 considered significant.
Results
The CCl4 -treated animals exhibited a significant increase (P < 0.01) in plasma enzyme activity and bilirubin 
concentration compared with saline-treated control rats (Table 1).
 
Table 1: Effect of pre- and post- treatment with aqueous Cassia fistula leaves and bark on CCl4 induced liver 
damaged in albino Wistar rats.
 
Treatment Aspartate 
aminotransferase (U/L)
Alanine 
aminotransferase 
(U/L)
Alkaline 
phosphatase (U/L)
Bilirubin (µmole/
L)
Control 108.6±3.29 35.43±1.33 156.2±2.64 0.17±.03
CF Leaves pretreatment 134.6±3.12 46.80±1.78* 181.5±1.98* 0.19±.01
CF Leaves post treatment 124.0±4.27* 44.31±0.76* 193.2±4.82* 0.20±.01
CF Bark pretreatment 163.1±4.63* 59.60±1.56* 180.90±3.03* 0.21±.01
CF Bark post treatment 158.7±6.45* 56.90±1.23* 171.8±10.13 0.20±0.00
Carbon tetrachloride 283.4±2.99* 85.6±1.99* 253.6±5.45* 3.30±0.07*
 
CF: Cassia fistula; Data are expressed as ± SE (n=10), * Significantly different than control at P<0.01.
 
A significant reduction was found in elevated AST, ALT, and ALP values in rats subjected to both pre- and post-
treatments with the aqueous extracts of both leaves and bark. Liver enzyme values were higher in the four 
experimental groups than in the saline-treated controls, but the liver enzyme values were decreased to about half of 
those found in CCl4 -treated control animals for all liver function tests except bilirubin. Expressed in percentage of 
protection provided, both Cassia fistula leaves and bark given pre- or post-treatment were hepatoprotective (Table 2).
 
Table 2:  Hepatoprotective activity of leaves and bark of Cassia fistula in CCl4 induced hepatotoxicity in albino 
Wistar rats.
 
Clinical chemistry liver 
function indicator
Aspartate 
aminotransferase 
Alanine 
aminotransferase 
Alkaline 
phosphatase 
Bilirubin 
CF Leaves pretreatment 
(% protection)
83.06 76.60 75.16 99.23
CF Leaves post 
treatment (% protection) 
89.89 82.32 61.97 99.07
CF Bark pretreatment 
 (% protection)
68.66 51.11 71.37 96.03
CF Bark post treatment 
(% protection)
71.23 54.99 82.54 99.03
 
CF: Cassia fistula; % Protection = 1-(PC-S)/ (C-S) × 100, where PC, C and S are the measurable variables in rats treated with CF leaves or 
bark extract with CCl4, CCl4 and saline treated animals respectively
 
Discussion
Liver cirrhosis induced by CCl4 is perhaps the best-studied model of liver cirrhosis4 .Several mechanisms underlying 
this toxicity have been suggested5. The reduction of CCl4 -induced elevated plasma activities of AST, ALT, ALP, and 
bilirubin level in animals pre- and post-treated with the aqueous extracts of Cassia fistula leaves and bark showed 
 their ability to restore the normal functional status of the poisoned liver and also to protect against subsequent CCl4 
hepatotoxicity. The mechanism by which the fruits pulp and seeds induces its hepatoprotective activity is not certain. 
The inactive metabolite (CCl4), is transformed to a free radical through the microsomal cytochrome P-450-dependent 
enzyme, resulting in activation of CCl4 toxicity. Hepatoprotective activity of any drug is the ability of its constituents 
to inhibit the aromatase activity of cytochrome P-450, thereby favoring liver regeneration. On that basis, it is 
suggested that flavonoids in Cassia fistula could be a factor for exhibiting the hepatoprotective activity.
 
 Conclusion
This study clearly demonstrates that aqueous extracts of Cassia fistula leaves and bark are effective in the treatment 
and prevention of CCl4 -induced hepatic cytotoxicity. The data suggest that the daily oral consumption of an aqueous 
extract of the Cassia fistula leaves and bark may alleviate CCl4 toxicity and provide protection to liver. This research 
work supports its traditional use for the treatment of hepatic disorder.
 
 
REFERENCES 
1.                          Preussmann R 1978. Hepatocarcinogens as potential risk for human liver cancer. In: 
Remmer H, Bolt HM, Bannasch P (eds). Primary liver tumors. Lancaster: MTP Press; pp. 11-29.
2.                          Ramchandran K (ed.) 1992. The Wealth of India, A Dictionary of Indian Raw Materials 
and Industrial Products, Vol-3, Ca-Ci. CSIR, New Delhi.
3.                          Singh B, Saxena AK, Chandan BK 1998. Hepatoprotective activity of verbenalin on 
experimental liver damage in rodents. Fitoterapia 69:135-40.
4.                          Cornelius CE 1993. Animal models in liver research . San Diego: Academic Press; pp. 
341.
5.                          Recknagel RO, Glender EA, Dolak JA, Waller RL 1989. Mechanisms of carbon 
tetrachloride toxicity. Pharmacol Ther43:139-54.
 
 
 
 
 
 
 
 
